by Allison Sit Dermatology Advisor, Dermatology News, Healio, Medriva and Medscape all covered a Journal of Drugs in Dermatology study about the long-term safety and effectiveness of topical clascoterone for…
Read More
by Allison Sit The Journal of Drugs in Dermatology made news in Healio recently with several articles including one about a combination therapy for non-melanoma skin cancer. The study, “Cryosurgery…
Read More
by Allison Sit Healio wrote about a recent Journal of Drugs in Dermatology study on telehealth usage from a physician’s perspective. The study, “Telemedicine Versus Teledermatology Usage and Perception Among…
Read More
2023 JDD Welcome Kit The Journal of Drugs in Dermatology (JDD) and its sponsors are welcoming the latest dermatology residency graduates into the specialty. Graduates from 2023 are each receiving…
Read More
by Allison Sit A Journal of Drugs in Dermatology study on the availability of oral minoxidil made news in several media outlets, including NBC News, HealthDay, Practical Dermatology and Dermatology…
Read More
Healio featured several September JDD studies in its recent dermatology news coverage including a study on using fractional lasers for skin cancer prevention. The study, “Fractional Laser for Prevention of…
Read More
Dermatology Times featured a JDD study on whether race plays a factor in access to biologics. The study, “No Racial Differences Found in Access to Biologics: A Population-Based Study of…
Read More
Healio featured a JDD study on the use of tildrakizumab for plaque psoriasis. Jayme Heim, MSN, FNP-BC, and colleagues wrote, “Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe…
Read More
Sponsored by Join the Journal of Drugs in Dermatology and Nutrafol in recognizing Hair Loss Awareness Month this August. This month aims to raise awareness how common hair thinning…
Read More
Click Here to View Video Abstract Importance: Managing chronic conditions is an essential aspect of dermatologic care, especially regarding the resolution of inflammatory dermatologic disease and recovery of skin lesions. Short-term…
Read More
Click Here to Watch Video Abstract Background: Patients with skin of color (SOC), defined as Fitzpatrick skin types IV to VI, and of varying ethnicities are under-represented in dermatology. This…
Read More
Healio covered a JDD study on the impact of an increased dose of adalimumab in hidradenitis suppurativa patients who are overweight or obese. Researchers from the University of California San…
Read More
